CLINICAL TRIALS:

THE EFFICACY AND SAFETY OF SUBCUTANEOUS TETRODOTOXIN FOR MODERATE TO SEVERE CANCER-RELATED PAIN
View All
NEWS
August 25, 2010
WEX Announces Poster Presentation at Scientific Conference
August 13, 2010
WEX Reports Second Quarter Results
July 19, 2010
President’s Message #12
July 12, 2010
WEX Receives Unsolicited Proposal to Purchase from Pharmagesic


INVESTOR RELATIONS:

TO VIEW OUR FINANCIAL REPORTS AND RECENT PRESS RELEASES CLICK HERE
Copyright WEX Phamaceuticals Inc. All Rights Reserved.
Powered By Q4 Web Systems 3.5.9.1419